For Patients With Myelodysplastic Syndrome, New Treatment Option Rytelo Could Reduce Need for Blood Transfusions & Improve Quality of Life

The FDA has approved a new treatment, Imetelstat Rytelo, for myelodysplastic syndrome MDS, reducing the need for regular blood transfusions.